Literature DB >> 6340754

The smoldering myeloid leukemic states: clinical and biologic features.

P L Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6340754

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Analysis of human dysplastic haematopoiesis in long-term bone marrow culture.

Authors:  V Gebbia; V Miserendino; S Miceli; A Colucci; M T Reyes; L Rausa; P Di Marco; P Citarrella
Journal:  Blut       Date:  1989-11

2.  Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease.

Authors:  Manuel Aivado; Dimitrios Spentzos; Ulrich Germing; Gil Alterovitz; Xiao-Ying Meng; Franck Grall; Aristoteles A N Giagounidis; Giannoula Klement; Ulrich Steidl; Hasan H Otu; Akos Czibere; Wolf C Prall; Christof Iking-Konert; Michelle Shayne; Marco F Ramoni; Norbert Gattermann; Rainer Haas; Constantine S Mitsiades; Eric T Fung; Towia A Libermann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-12       Impact factor: 11.205

3.  Pathology-important advances in clinical medicine: assessing fetal lung maturity.

Authors:  R K Wertz
Journal:  West J Med       Date:  1984-07

4.  Ocular complications in myelodysplastic syndromes as preleukemic disorders.

Authors:  Takeshi Kezuka; Norio Usui; Etsuko Suzuki; Kazunori Wakasugi; Masahiko Usui
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

5.  Enhanced growth of myelodysplastic colonies in hypoxic conditions.

Authors:  James Edwin Thompson; Joseph Patrick Conlon; Xiaowei Yang; Patricia Vanessa Sanchez; Martin Carroll
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

Review 6.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

Review 7.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Leukocyte-derived inhibitory activity in patients with myelodysplastic syndrome.

Authors:  V Cukrová; R Neuwirtová; J Cermák; V Malasková; J Neuwirt
Journal:  Blut       Date:  1987-09

9.  Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features.

Authors:  I Fohlmeister; R Fischer; B Mödder; M Rister; H E Schaefer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

10.  Blood group change in a patient with blastic transformation of a myelodysplastic syndrome.

Authors:  N Xiros; H Northoff; B Anger; W Heit; H Heimpel
Journal:  Blut       Date:  1987-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.